drugset / Trial / NCT00849264

Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

NCT00849264

Phase 2 Completed 120 enrolled Eastern Hepatobiliary Surgery Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is working to evaluate the surgical comprehensive treatment for different types of tumor thrombi in the portal vein for hepatocellular carcinoma patients, to establish a standardized, unified, effective therapeutic program.

Timeline

Start
2008-12
Primary completion
2009-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator CBP Unknown 300 mg Other
Subject Endostar Protein / enzyme biologic 15 mg Other
Comparator fluorouracil Small molecule 1000 mg Other